Showing results (1-10 of 451) with videos related to
Sort By:
Pageof 46
Transplantation|July 16, 2008
Randomization is essential for progress in transplant medicineColin Baigent, Jonathan R EmbersonPlos One|January 26, 2012
Lack of effect of lowering LDL cholesterol on cancer: meta-analysis of individual data from 175,000 people in 27 randomised trials of statin therapy, Jonathan R Emberson, Patricia M Kearney, et al.Clinical Trials (London, England)|February 20, 2008
Ensuring trial validity by data quality assurance and diversification of monitoring methodsColin Baigent, Frank E Harrell, Marc Buyse, et al.Kidney International|April 22, 2019
Cost-effectiveness of lipid lowering with statins and ezetimibe in chronic kidney diseaseIryna Schlackow, Seamus Kent, William Herrington, et al.BMJ (Clinical Research Ed.)|June 3, 2006
Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trialsPatricia M Kearney, Colin Baigent, Jon Godwin, et al.Journal of the American College of Cardiology|April 25, 2020
Lipid-Modifying Agents, From Statins to PCSK9 Inhibitors: JACC Focus SeminarDavid Preiss, Jonathan A Tobert, G Kees Hovingh, et al.Journal of the American College of Cardiology|January 24, 2007
N-terminal Pro-B-type natriuretic peptide, vascular disease risk, and cholesterol reduction among 20,536 patients in the MRC/BHF heart protection study, Jonathan R Emberson, Leong L Ng, et al.The New England Journal of Medicine|September 4, 2008
Analyses of cancer data from three ezetimibe trialsRichard Peto, Jonathan Emberson, Martin Landray, et al.The Lancet. Gastroenterology & Hepatology|February 25, 2018
Effects of gastroprotectant drugs for the prevention and treatment of peptic ulcer disease and its complications: a meta-analysis of randomised trialsBenjamin Scally, Jonathan R Emberson, Enti Spata, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 25, 2015
Cost-effectiveness of Simvastatin plus Ezetimibe for Cardiovascular Prevention in CKD: Results of the Study of Heart and Renal Protection (SHARP)Borislava Mihaylova, Iryna Schlackow, William Herrington, et al.Pageof 46